Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by TODD ROSENGART and MEGUMI MATHISON.
TODD ROSENGART
Connection Strength
5.328
MEGUMI MATHISON
  1. Fibroblast transition to an endothelial "trans" state improves cell reprogramming efficiency. Sci Rep. 2021 11 19; 11(1):22605.
    View in: PubMed
    Score: 0.807
  2. Heart regeneration: The endothelial cell comes first. J Thorac Cardiovasc Surg. 2018 03; 155(3):1128-1129.
    View in: PubMed
    Score: 0.606
  3. Cardiac reprogramming factor Gata4 reduces postinfarct cardiac fibrosis through direct repression of the profibrotic mediator snail. J Thorac Cardiovasc Surg. 2017 11; 154(5):1601-1610.e3.
    View in: PubMed
    Score: 0.594
  4. In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration. J Thorac Cardiovasc Surg. 2017 02; 153(2):329-339.e3.
    View in: PubMed
    Score: 0.564
  5. "Triplet" polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors. J Thorac Cardiovasc Surg. 2014 Oct; 148(4):1656-1664.e2.
    View in: PubMed
    Score: 0.475
  6. In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor. J Am Heart Assoc. 2012 Dec; 1(6):e005652.
    View in: PubMed
    Score: 0.435
  7. Activation of a GPCR, ORL1 Receptor: A Novel Therapy to Prevent Heart Failure Progression. J Cardiovasc Dev Dis. 2024 Nov 05; 11(11).
    View in: PubMed
    Score: 0.248
  8. Activation of a GPCR, ORL1 receptor: A novel therapy to prevent heart failure progression. Res Sq. 2024 Jul 18.
    View in: PubMed
    Score: 0.243
  9. Direct cardiac reprogramming: A new technology for cardiac repair. J Mol Cell Cardiol. 2023 05; 178:51-58.
    View in: PubMed
    Score: 0.221
  10. p63 silencing induces epigenetic modulation to enhance human cardiac fibroblast to cardiomyocyte-like differentiation. Sci Rep. 2022 07 06; 12(1):11416.
    View in: PubMed
    Score: 0.211
  11. Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte Reprogramming. J Am Heart Assoc. 2021 12 21; 10(24):e022659.
    View in: PubMed
    Score: 0.203
  12. Enhanced Generation of Induced Cardiomyocytes Using a Small-Molecule Cocktail to Overcome Barriers to Cardiac Cellular Reprogramming. J Am Heart Assoc. 2020 06 16; 9(12):e015686.
    View in: PubMed
    Score: 0.182
  13. p63 Silencing induces reprogramming of cardiac fibroblasts into cardiomyocyte-like cells. J Thorac Cardiovasc Surg. 2018 08; 156(2):556-565.e1.
    View in: PubMed
    Score: 0.157
  14. MiR-590 Promotes Transdifferentiation of Porcine and Human Fibroblasts Toward a Cardiomyocyte-Like Fate by Directly Repressing Specificity Protein 1. J Am Heart Assoc. 2016 11 10; 5(11).
    View in: PubMed
    Score: 0.142
  15. Direct Cardiac Cellular Reprogramming for Cardiac Regeneration. Curr Treat Options Cardiovasc Med. 2016 Sep; 18(9):58.
    View in: PubMed
    Score: 0.141
  16. Sall4 and Gata4 induce cardiac fibroblast transition towards a partially multipotent state with cardiogenic potential. Sci Rep. 2024 10 15; 14(1):24182.
    View in: PubMed
    Score: 0.062
  17. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis. J Hematol Oncol. 2017 10 03; 10(1):159.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.